Bridge Biotherapeutics (XKRX:288330) Interest Income : ₩0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Bridge Biotherapeutics's interest income for the three months ended in Mar. 2024 was ₩0.0 Mil. Its interest income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0.0 Mil.

Bridge Biotherapeutics Interest Income Historical Data

The historical data trend for Bridge Biotherapeutics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bridge Biotherapeutics Interest Income Chart

Bridge Biotherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Income

Get a 7-Day Free Trial

140.60

208.73

350.68

950.97

1,034.08

Bridge Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Income	Get a 7-Day Free Trial															-	-	-	-	-

Bridge Biotherapeutics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.0 Mil.

Bridge Biotherapeutics (XKRX:288330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486

Website

http://www.bridgebiorx.com

Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.

Bridge Biotherapeutics (XKRX:288330) Headlines

No Headlines